The roles of miRNAs as potential biomarkers in lung diseases

Shamila D. Alipoor, Ian M. Adcock, Johan Garssen, Esmaeil Mortaz, Mohammad Varahram, Mehdi Mirsaeidi, Aliakbar Velayati

Research output: Contribution to journalReview articlepeer-review

86 Scopus citations


MicroRNAs (miRNAs) are small non-coding RNAs which can act as master regulators of gene expression, modulate almost all biological process and are essential for maintaining cellular homeostasis. Dysregulation of miRNA expression has been associated with aberrant gene expression and may lead to pathological conditions. Evidence suggests that miRNA expression profiles are altered between health and disease and as such may be considered as biomarkers of disease. Evidence is increasing that miRNAs are particularly important in lung homeostasis and development and have been demonstrated to be the involved in many pulmonary diseases such as asthma, COPD, sarcoidosis, lung cancer and other smoking related diseases. Better understanding of the function of miRNA and the mechanisms underlying their action in the lung, would help to improve current diagnosis and therapeutics strategies in pulmonary diseases. Recently, some miRNA-based drugs have been introduced as possible therapeutic agents. In this review we aim to summarize the recent findings regarding the role of miRNAs in the airways and lung and emphasise their potential therapeutic roles in pulmonary diseases.

Original languageEnglish (US)
Pages (from-to)395-404
Number of pages10
JournalEuropean Journal of Pharmacology
StatePublished - 2016


  • Asthma
  • COPD
  • Lung cancer
  • Lung disease
  • MicroRNA
  • Sarcoidosis

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'The roles of miRNAs as potential biomarkers in lung diseases'. Together they form a unique fingerprint.

Cite this